CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 55 filers reported holding CTI BIOPHARMA CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,410,000 | +8.9% | 3,459,402 | 0.0% | 0.00% | – |
| Q3 2016 | $1,295,000 | +10.1% | 3,459,402 | 0.0% | 0.00% | – |
| Q2 2016 | $1,176,000 | -61.1% | 3,459,402 | -39.1% | 0.00% | – |
| Q1 2016 | $3,021,000 | -53.6% | 5,684,666 | +7.4% | 0.00% | -100.0% |
| Q4 2015 | $6,507,000 | -4.0% | 5,290,591 | +14.0% | 0.00% | 0.0% |
| Q3 2015 | $6,775,000 | -30.4% | 4,640,536 | -7.0% | 0.00% | -50.0% |
| Q2 2015 | $9,734,000 | +5.7% | 4,991,768 | -1.9% | 0.00% | +100.0% |
| Q1 2015 | $9,213,000 | -22.9% | 5,089,960 | +0.5% | 0.00% | -50.0% |
| Q4 2014 | $11,951,000 | +1.3% | 5,064,034 | +3.9% | 0.00% | 0.0% |
| Q3 2014 | $11,797,000 | -9.6% | 4,874,936 | +4.9% | 0.00% | 0.0% |
| Q2 2014 | $13,054,000 | – | 4,645,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST NEW YORK SECURITIES LLC /NY | 191,000 | $345,710,000 | 0.34% |
| TFS CAPITAL LLC | 1,182,304 | $2,140,000 | 0.21% |
| TURNER INVESTMENTS LLC | 530,100 | $959,000 | 0.17% |
| DRW Securities, LLC | 486,953 | $881,000 | 0.14% |
| Candriam S.C.A. | 1,445,000 | $2,616,000 | 0.05% |
| First Heartland Consultants, Inc. | 74,624 | $135,000 | 0.05% |
| WASHINGTON TRUST Co | 410,616 | $743,000 | 0.05% |
| EAGLE ASSET MANAGEMENT INC | 4,332,630 | $7,842,000 | 0.04% |
| JW Asset Management, LLC | 52,271 | $95,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 702,571 | $1,272,000 | 0.03% |